Related Experiment Video
Updated: Apr 24, 2026
08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
6.9K
Inflammatory response in Parkinson's disease (Review)
Junqiang Yan1, Qizhi Fu1, Liniu Cheng1
1Department of Neurology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Molecular Medicine Reports
|September 13, 2014
Summary
Parkinson's disease (PD) involves the degeneration of dopaminergic neurons, exacerbated by neuroinflammation. This review explores inflammatory pathways in PD and proposes anti-inflammatory strategies to slow disease progression.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Parkinson's disease (PD) is a common age-related neurodegenerative disorder.
- It is characterized by the progressive loss of dopaminergic neurons in the substantia nigra.
- Neuroinflammation significantly contributes to the pathogenesis of PD.
Purpose of the Study:
- To review current knowledge on inflammation in Parkinson's disease.
- To examine the roles of intracellular inflammatory signaling pathways and mediators in PD.
- To propose therapeutic strategies targeting inflammation to inhibit PD progression.
Main Methods:
- Literature review of studies on neuroinflammation and Parkinson's disease.
- Analysis of intracellular inflammatory signaling pathways implicated in PD pathogenesis.
- Identification and discussion of potential anti-inflammatory therapeutic targets.
Main Results:
- Neuroinflammation is a key factor in the degeneration of dopaminergic neurons in PD.
- Specific intracellular signaling pathways and inflammatory mediators play crucial roles in PD.
- Anti-inflammatory agents represent a promising therapeutic avenue for PD.
Conclusions:
- Understanding neuroinflammatory processes is critical for developing effective PD treatments.
- Targeting inflammatory pathways offers a novel strategy to slow or halt the progression of Parkinson's disease.
- Further research into anti-inflammatory therapies is warranted for PD management.
